• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度肾功能不全的冠状动脉搭桥术患者的围手术期及中期预后

Perioperative and mid-term prognosis in coronary artery bypass grafting patients with mild renal dysfunction.

作者信息

Wang Wuwei, Cao Xu, Wu Yukai, Liu Quan, Zhou Yifei, Fan Rui, Chen Xin, Wang Rui

机构信息

Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

School of Medicine, Southeast University, Nanjing, China.

出版信息

Ren Fail. 2025 Dec;47(1):2539944. doi: 10.1080/0886022X.2025.2539944. Epub 2025 Aug 7.

DOI:10.1080/0886022X.2025.2539944
PMID:40772319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12333037/
Abstract

OBJECTIVE

Renal dysfunction is the most common risk factor for patients with coronary artery bypass grafting (CABG). The aim of this research was to evaluate the prognosis and mid-term outcomes in CABG patients with mild renal dysfunction.

METHODS

Patients undergoing isolated CABG from July 2020 to December 2022 in Nanjing First Hospital were selected into this cohort study and divided into normal renal function group (eGFR ≥ 90 mL/min/1.73 m, corresponding to CKD G1) and mild renal dysfunction group (eGFR: 60-89 mL/min/1.73 m, corresponding to CKD G2). Propensity score matching was used to balance the differences. The primary outcomes were acute kidney injury (AKI) and all-cause mortality in follow-up, while the secondary outcomes were perioperative mortality and major adverse cardiac and cerebrovascular event (MACCE) including death, stroke, myocardial infarction, and revascularization.

RESULTS

Totally 1,097 patients were enrolled in this study and 416 (33.3%) had mild renal dysfunction. A total of 379 pairs were included to the analysis after propensity score matching. Compared with the normal renal function, patients with mild renal dysfunction had more AKI after CABG (26.1% vs. 18.7%,  = 0.015), however, the perioperative mortality (1.3% vs. 1.3%,  = 1.00) was not significantly different. At 3-year follow-up, there were also no significant differences in all-cause mortality (6.3% vs. 4.8%, log-rank  = 0.33, HR 1.38, 95%CI: 0.721-2.652) and MACCE rates (10.2% vs. 7.6%, log-rank  = 0.19, HR 1.42, 95%CI: 0.836-2.414).

CONCLUSION

For patients undergoing CABG, preoperative renal dysfunction is associated with an increased risk of postoperative AKI. However, no significant difference was observed in perioperative mortality and mid-term outcomes.

摘要

目的

肾功能不全是冠状动脉旁路移植术(CABG)患者最常见的危险因素。本研究旨在评估轻度肾功能不全的CABG患者的预后和中期结局。

方法

选取2020年7月至2022年12月在南京第一医院接受单纯CABG的患者纳入本队列研究,分为肾功能正常组(eGFR≥90 mL/min/1.73 m²,对应CKD G1期)和轻度肾功能不全组(eGFR:60 - 89 mL/min/1.73 m²,对应CKD G2期)。采用倾向得分匹配法平衡差异。主要结局为随访期间的急性肾损伤(AKI)和全因死亡率,次要结局为围手术期死亡率和主要不良心脑血管事件(MACCE),包括死亡、中风、心肌梗死和血运重建。

结果

本研究共纳入1097例患者,其中416例(33.3%)有轻度肾功能不全。倾向得分匹配后共纳入379对进行分析。与肾功能正常者相比,轻度肾功能不全患者CABG术后发生AKI的比例更高(26.1%对18.7%,P = 0.015),然而围手术期死亡率(1.3%对1.3%,P = 1.00)无显著差异。在3年随访时,全因死亡率(6.3%对4.8%,log-rank P = 0.33,HR 1.38,95%CI:0.721 - 2.652)和MACCE发生率(10.2%对7.6%,log-rank P = 0.19,HR 1.42,95%CI:0.836 - 2.414)也无显著差异。

结论

对于接受CABG的患者,术前肾功能不全与术后AKI风险增加相关。然而,围手术期死亡率和中期结局未观察到显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/04577ef24172/IRNF_A_2539944_F0003b_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/3092ced50d3c/IRNF_A_2539944_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/d6654fec9455/IRNF_A_2539944_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/bf74361808f6/IRNF_A_2539944_F0003a_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/04577ef24172/IRNF_A_2539944_F0003b_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/3092ced50d3c/IRNF_A_2539944_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/d6654fec9455/IRNF_A_2539944_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/bf74361808f6/IRNF_A_2539944_F0003a_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f45d/12333037/04577ef24172/IRNF_A_2539944_F0003b_C.jpg

相似文献

1
Perioperative and mid-term prognosis in coronary artery bypass grafting patients with mild renal dysfunction.轻度肾功能不全的冠状动脉搭桥术患者的围手术期及中期预后
Ren Fail. 2025 Dec;47(1):2539944. doi: 10.1080/0886022X.2025.2539944. Epub 2025 Aug 7.
2
The Role of Other Major Postoperative Complications in Determining Outcomes of Acute Kidney Injury After Coronary Artery Bypass Surgery.其他主要术后并发症在冠状动脉搭桥手术后急性肾损伤结局判定中的作用
Acta Anaesthesiol Scand. 2025 Sep;69(8):e70110. doi: 10.1111/aas.70110.
3
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
4
Predictability of kinetic estimated glomerular filtration rate for acute kidney injury in patients undergoing coronary artery bypass surgery.冠状动脉搭桥手术患者急性肾损伤的动态估计肾小球滤过率的可预测性
BMC Nephrol. 2025 Jul 21;26(1):409. doi: 10.1186/s12882-025-04266-1.
5
Survival and Mid-Term Outcomes of On Pump vs. Off Pump Coronary Artery Bypass Grafting: A Propensity Score-Matched Analysis in A First Peruvian Registry.在泵与非在泵冠状动脉旁路移植术的生存和中期结果:秘鲁首个注册研究中的倾向评分匹配分析。
Braz J Cardiovasc Surg. 2024 Nov 28;e20230242(e20230242):e20230242. doi: 10.21470/1678-9741-2023-0242.
6
Comparison of hybrid coronary revascularization versus conventional Coronary Artery Bypass surgery in patients with multi-vessel coronary artery disease in a real-world setting: In-hospital outcomes and medium-term follow-up: COHOS study.真实世界中多支冠状动脉疾病患者杂交冠状动脉血运重建与传统冠状动脉搭桥手术的比较:住院结局及中期随访:COHOS研究
Indian Heart J. 2025 Mar-Apr;77(2):98-104. doi: 10.1016/j.ihj.2025.03.002. Epub 2025 Mar 5.
7
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes.糖尿病患者中,基于血流储备分数(FFR)指导的经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较
JAMA Cardiol. 2025 Jun 1;10(6):603-608. doi: 10.1001/jamacardio.2025.0095.
8
Do nonfatal events during the first 5 years after coronary artery bypass surgery influence 10 year outcomes?冠状动脉搭桥手术后前5年的非致命性事件会影响10年的预后吗?
J Thorac Cardiovasc Surg. 2025 Aug;170(2):568-578.e4. doi: 10.1016/j.jtcvs.2024.09.034. Epub 2024 Sep 25.
9
Surgical Myocardial Revascularization with a Composite T-graft from the Left Internal Mammary Artery-Comparison of the Great Saphenous Vein with the Radial Artery.左内乳动脉复合 T 型移植物行冠状动脉旁路移植术——大隐静脉与桡动脉的比较。
Thorac Cardiovasc Surg. 2024 Sep;72(6):413-422. doi: 10.1055/s-0043-1771358. Epub 2023 Jul 28.
10
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄患者:系统评价与荟萃分析
Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.

本文引用的文献

1
Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery: A Pooled Analysis of 2 Randomized Clinical Trials.谷氨酸输注与冠状动脉旁路手术后急性肾损伤风险的关联:2 项随机临床试验的汇总分析。
JAMA Netw Open. 2024 Jan 2;7(1):e2351743. doi: 10.1001/jamanetworkopen.2023.51743.
2
Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.靶向抑制 CX3CL1 可抑制足细胞铁死亡从而减轻顺铂诱导的急性肾损伤。
Mol Med. 2023 Oct 24;29(1):140. doi: 10.1186/s10020-023-00733-3.
3
Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study.
三血管病变患者轻度肾功能损害与长期预后的关系:一项队列研究。
Cardiorenal Med. 2023;13(1):354-362. doi: 10.1159/000534252. Epub 2023 Oct 12.
4
Chronic kidney disease, risk of readmission, and progression to end-stage renal disease in 519,387 patients undergoing coronary artery bypass grafting.519387例行冠状动脉搭桥术患者的慢性肾脏病、再入院风险及终末期肾病进展情况
JTCVS Open. 2022 Sep 16;12:147-157. doi: 10.1016/j.xjon.2022.08.013. eCollection 2022 Dec.
5
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.慢性肾脏病患者的心血管疾病流行病学和风险。
Nat Rev Nephrol. 2022 Nov;18(11):696-707. doi: 10.1038/s41581-022-00616-6. Epub 2022 Sep 14.
6
Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.多支冠状动脉血运重建术患者轻度肾功能不全的预后影响。
J Am Coll Cardiol. 2022 Apr 5;79(13):1270-1284. doi: 10.1016/j.jacc.2022.01.035.
7
Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery.血管紧张素II受体阻滞剂而非血管紧张素转换酶抑制剂与大手术后急性肾损伤风险降低相关。
Front Pharmacol. 2021 Apr 23;12:662301. doi: 10.3389/fphar.2021.662301. eCollection 2021.
8
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病:病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
9
Chronic Kidney Disease-Associated Inflammation Increases the Risks of Acute Kidney Injury and Mortality after Cardiac Surgery.慢性肾脏病相关性炎症增加心脏手术后急性肾损伤和死亡的风险。
Int J Mol Sci. 2020 Dec 18;21(24):9689. doi: 10.3390/ijms21249689.
10
Impact of Different Cardiopulmonary Bypass Strategies on Renal Injury After Pediatric Heart Surgery.不同体外循环策略对小儿心脏手术后肾损伤的影响。
Ann Thorac Surg. 2021 Apr;111(4):1374-1379. doi: 10.1016/j.athoracsur.2020.05.056. Epub 2020 Jun 27.